Ana Krivokuća
- Co-authors
- Milena ČavićRadmila JankovićEnric I. CanelaEstefanía MorenoEmina MališićVicent CasadóMirjana Branković-MagićIvana Z. Matić
- Topics
- BRCA gene mutations in cancer (9 papers)Genetic factors in colorectal cancer (7 papers)DNA Repair Mechanisms (6 papers)
- Cited by
- OncologyPharmacologyCancer Research
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaScientific Reports
- Partner nations
- SerbiaUnited KingdomSpain
In The Last Decade
Ana Krivokuća
45 papers receiving 550 citations
Peers
Comparison fields: 5 of 78
- Molecular Biology 188
- Oncology 179
- Pharmacology 107
- Cancer Research 95
- Organic Chemistry 92
Countries citing papers authored by Ana Krivokuća
This map shows the geographic impact of Ana Krivokuća's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Krivokuća with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Krivokuća more than expected).
Fields of papers citing papers by Ana Krivokuća
This network shows the impact of papers produced by Ana Krivokuća. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Krivokuća. The network helps show where Ana Krivokuća may publish in the future.
Co-authorship network of co-authors of Ana Krivokuća
This figure shows the co-authorship network connecting the top 25 collaborators of Ana Krivokuća. A scholar is included among the top collaborators of Ana Krivokuća based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Krivokuća. Ana Krivokuća is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 12 | |
| 5 | 5 | |
| 6 | 14 | |
| 7 | EGFR mutation testing from liquid biopsy of non-small cell lung cancer at the Institute for Oncology and Radiology of Serbia. | 6 |
| 8 | 13 | |
| 9 | 1 | |
| 10 | Promoter hypermethylation of p16, BRCA1 and RASSF1A genes in triple-negative breast cancer patients from Serbia. | 12 |
| 11 | Overall human papilloma virus and types 16/18 prevalence in women with normal cervical cytology in Serbia: is it time for human papillomavirus testing and/or vaccination? | 4 |
| 12 | 16 | |
| 13 | 18 | |
| 14 | Pharmacogenetics in cancer therapy - 8 years of experience at the Institute for Oncology and Radiology of Serbia. | 12 |
| 15 | 40 | |
| 16 | 15 | |
| 17 | 30 | |
| 18 | 11 | |
| 19 | KRAS and BRAF mutations in Serbian patients with colorectal cancer. | 20 |
| 20 | 9 |
About Ana Krivokuća
Ana Krivokuća is a scholar working on Oncology, Cancer Research and Aging, having authored 46 papers that have together received 559 indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (9 papers), Genetic factors in colorectal cancer (7 papers) and DNA Repair Mechanisms (6 papers). The work is most often cited by research in Oncology (179 citations), Pharmacology (107 citations) and Cancer Research (95 citations). Ana Krivokuća has collaborated with scholars based in Serbia, United Kingdom and Spain. Frequent co-authors include Milena Čavić, Radmila Janković, Enric I. Canela, Estefanía Moreno, Emina Mališić, Vicent Casadó, Mirjana Branković-Magić, Ivana Z. Matić, Siniša Radulović and Tatjana Stanojković. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.